CAAS Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,000	Closed	-$528K	–	349
2022 Q4	$528K	Buy	+13,000	New	+$528K	0.03%	134
2021 Q2	–	Hold	0	–	–	–	745
2021 Q1	–	Hold	0	–	–	–	788